BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 9, 2016
View Archived Issues
Lexicon Pharmaceuticals obtains exclusive rights to LX-9211
Read More
Eloxx Pharmaceuticals reports orphan drug designations for ELX-02 from both FDA and EMA
Read More
Pfizer reviews key milestones of third quarter 2016
Read More
CTDP1 as a novel diagnostic biomarker of Behcet disease
Read More
FDA puts full clinical hold on phase II study of BI-505
Read More
Mylan submits BLA to FDA for proposed trastuzumab biosimilar
Read More
Sentinel Oncology patents p70S6K inhibitors
Read More
FORMA Therapeutics discloses mutant IDH1 inhibitors
Read More
Positive interim data from an ongoing early clinical trial of CC-31244
Read More
Araxes Pharma describes mutant K-RAS, H-RAS or N-RAS inhibitors
Read More
Takeda Pharmaceutical develops SPT inhibitors
Read More
Shionogi presents P2X7 antagonists
Read More
DNAtrix in license agreement with University of Florida to develop novel oncolytic virus platform
Read More
Sorrento Therapeutics closes Scilex acquisition
Read More
BenevolentAI signs exclusive license agreement with Janssen Pharmaceutica
Read More
FDA places clinical hold on Heparc-2004 study of ARC-520
Read More
Biotest initiates phase III study of IgG Next Generation for primary immunodeficiency disease
Read More
CiRA, Takeda and Yokohama City University enter joint research agreement
Read More
ProMIS Neurosciences evaluates prevalence of different amyloid beta prion strains in AD
Read More
miR-144-3p/survivin may be useful as a target to overcome chemoresistance in NSCLC
Read More
Placon Therapeutics initiates phase I trial of BTP-114 for advanced solid tumors with BRCA mutations
Read More
PhaseRx reports positive results from animal study of PRX-OTC
Read More
MRC Technology, UCB and University of Leicester form research consortium
Read More
FKBP5 methylation levels are decreased in patients with schizophrenia
Read More
5T4 oncofetal antigen as a promising target for immune intervention in cancer
Read More
Phosphatidylinositol shows promise as a biomarker for bipolar disorder
Read More